In vitro effects of trastuzumab and vinorelbine in trastuzumab-resistant breast cancer cells

被引：0
|
作者：
Rita Nahta
Francisco J. Esteva
机构：
[1] The University of Texas M. D. Anderson Cancer Center,Department of Breast Medical Oncology
[2] The University of Texas M. D. Anderson Cancer Center,Department of Molecular and Cellular Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2004年 / 53卷
关键词：
Apoptosis; Dose-response; Herceptin; Resistance; SKBR3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：186 / 190
页数：4
相关论文
共 50 条
  • [21] Alterations in mRNA profiles of trastuzumab-resistant Her-2-positive breast cancer
    Zhao, Bin
    Zhao, Yang
    Sun, Yan
    Niu, Haitao
    Sheng, Long
    Huang, Dongfang
    Li, Li
    MOLECULAR MEDICINE REPORTS, 2018, 18 (01) : 139 - 146
  • [22] Lapatinib induces apoptosis in trastuzumab-resistant breast cancer cells: effects on insulin-like growth factor I signaling
    Nahta, Rita
    Yuan, Linda X. H.
    Du, Yi
    Esteva, Francisco J.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (02) : 667 - 674
  • [23] Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients
    Cheng, Y. C.
    Valero, V.
    Davis, M. L.
    Gonzalez-Angulo, A. M.
    Theriault, R. L.
    Murray, J. L.
    Hortobagyi, G. N.
    Ueno, N. T.
    BRITISH JOURNAL OF CANCER, 2010, 103 (09) : 1331 - 1334
  • [24] tRNA-Derived Fragments as Novel Predictive Biomarkers for Trastuzumab-Resistant Breast Cancer
    Sun, Chunxiao
    Yang, Fan
    Zhang, Yanhong
    Chu, Jiahui
    Wang, Jian
    Wang, Yifan
    Zhang, Yanqiu
    Li, Jun
    Li, Yongfei
    Fan, Ruihua
    Li, Wei
    Huang, Xiang
    Wu, Hao
    Fu, Ziyi
    Jiang, Zefei
    Yin, Yongmei
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (02) : 419 - 431
  • [25] Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron-emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate
    Costantini, Danny L.
    Bateman, Katherine
    McLarty, Kristin
    Vallis, Katherine A.
    Reilly, Raymond M.
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (09) : 1498 - 1505
  • [26] JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12
    Liang, Yan
    Qian, Chao
    Xie, Yinghong
    Huang, Xiang
    Chen, Junjie
    Ren, Yanlin
    Fu, Ziyi
    Li, Yongfei
    Zeng, Tianyu
    Yang, Fan
    Zhou, Jianwei
    Li, Wei
    Yin, Yongmei
    Wang, Changqing
    CELL DEATH DISCOVERY, 2021, 7 (01)
  • [27] Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer
    Taveira, Mateus de Oliveira
    Nabavi, Sheida
    Wang, Yuker
    Tonellato, Peter
    Esteva, Francisco J.
    Cantley, Lewis C.
    Wulf, Gerburg M.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (07) : 1255 - 1262
  • [28] Clinical observation of lapatinib versus continued use of trastuzumab for trastuzumab-resistant HER2-positive advanced breast cancer
    Yin, Yongmei
    Li, Wei
    Huang, Xiang
    Wang, Jian
    Fu, Ziyi
    Li, Jun
    CANCER RESEARCH, 2018, 78 (04)
  • [29] tRNA-derived fragments as novel predictive biomarkers for trastuzumab-resistant breast cancer
    Sun, C.
    Li, W.
    Wu, H.
    Huang, X.
    Li, J.
    Fu, Z.
    Tang, J.
    Yin, Y.
    CANCER RESEARCH, 2019, 79 (04)
  • [30] Addition of GM-CSF to trastuzumab stabilises disease in trastuzumab-resistant HER2+ metastatic breast cancer patients
    Y C Cheng
    V Valero
    M L Davis
    M C Green
    A M Gonzalez-Angulo
    R L Theriault
    J L Murray
    G N Hortobagyi
    N T Ueno
    British Journal of Cancer, 2010, 103 : 1331 - 1334
12345